{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:19:55Z","timestamp":1770977995753,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T00:00:00Z","timestamp":1242259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T00:00:00Z","timestamp":1242259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/gt.2009.43","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T10:19:15Z","timestamp":1242296355000},"page":"862-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of ciliary muscle plasmid electrotransfer of TNF-\u03b1 soluble receptor variants in experimental uveitis"],"prefix":"10.1038","volume":"16","author":[{"given":"E","family":"Touchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bloquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bigey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Kowalczuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Jonet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Thillaye-Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-C","family":"Naud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Scherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y de","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"BenEzra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,14]]},"reference":[{"key":"BFgt200943_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","volume":"23","author":"AD Dick","year":"2004","unstructured":"Dick AD, Forrester JV, Liversidge J, Cope AP . The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res 2004; 23: 617\u2013637.","journal-title":"Prog Retin Eye Res"},{"key":"BFgt200943_CR2","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1167\/iovs.02-0589","volume":"44","author":"K Koizumi","year":"2003","unstructured":"Koizumi K, Poulaki V, Doehmen S, Welsandt G, Radetzky S, Lappas A et al. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo. Invest Ophthalmol Vis Sci 2003; 44: 2184\u20132191.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200943_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000055677","volume":"33","author":"M Santos Lacomba","year":"2001","unstructured":"Santos Lacomba M, Marcos Mart\u00edn C, Gallardo Galera JM, G\u00f3mez Vidal MA, Collantes Est\u00e9vez E, Ram\u00edrez Chamond R et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 2001; 33: 251\u2013255.","journal-title":"Ophthalmic Res"},{"key":"BFgt200943_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","volume":"142","author":"JK Ahn","year":"2006","unstructured":"Ahn JK, Yu HG, Chung H, Park YG . Intraocular cytokine environment in active Beh\u00e7et uveitis. Am J Ophthalmol 2006; 142: 429\u2013434.","journal-title":"Am J Ophthalmol"},{"key":"BFgt200943_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ophtha.2006.01.004","volume":"113","author":"Y El-Shabrawi","year":"2006","unstructured":"El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S et al. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology 2006; 113: 695\u2013700.","journal-title":"Ophthalmology"},{"key":"BFgt200943_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1167\/iovs.04-0932","volume":"46","author":"NW Kuo","year":"2005","unstructured":"Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005; 46: 1565\u20131571.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200943_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cyto.2005.12.012","volume":"33","author":"S Hale","year":"2006","unstructured":"Hale S, Lightman S . Anti-TNF therapies in the management of acute and chronic uveitis. Cytokine 2006; 33: 231\u2013237.","journal-title":"Cytokine"},{"key":"BFgt200943_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/bjo.2003.037192","volume":"89","author":"EW Lindstedt","year":"2005","unstructured":"Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM . Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005; 89: 533\u2013536.","journal-title":"Br J Ophthalmol"},{"key":"BFgt200943_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007; 91: 319\u2013324.","journal-title":"Br J Ophthalmol"},{"key":"BFgt200943_CR10","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.ophtha.2006.04.038","volume":"113","author":"A Galor","year":"2006","unstructured":"Galor A, Perez VL, Hammel JP, Lowder CY . Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006; 113: 2317\u20132323.","journal-title":"Ophthalmology"},{"key":"BFgt200943_CR11","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/eji.1830260510","volume":"26","author":"AD Dick","year":"1996","unstructured":"Dick AD, McMenamin PG, K\u00f6rner H, Scallon BJ, Ghrayeb J, Forrester JV et al. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol 1996; 26: 1018\u20131025.","journal-title":"Eur J Immunol"},{"key":"BFgt200943_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/jaut.1998.0197","volume":"11","author":"AD Dick","year":"1998","unstructured":"Dick AD, Duncan L, Hale G, Waldmann H, Isaacs J . Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun 1998; 11: 255\u2013264.","journal-title":"J Autoimmun"},{"key":"BFgt200943_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1001\/archopht.122.6.845","volume":"122","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Greiner K, Plskova J, Duncan L, Frost A, Isaacs JD et al. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis. Arch Ophthalmol 2004; 122: 845\u2013851.","journal-title":"Arch Ophthalmol"},{"key":"BFgt200943_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1167\/iovs.03-0659","volume":"45","author":"K Greiner","year":"2004","unstructured":"Greiner K, Murphy CC, Willermain F, Duncan L, Plskova J, Hale G et al. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Invest Ophthalmol Vis Sci 2004; 45: 170\u2013176.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200943_CR15","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis. J Rheumatol 2004; 31: 1362\u20131368.","journal-title":"J Rheumatol"},{"key":"BFgt200943_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3949\/ccjm.73.3.251","volume":"73","author":"L Calabrese","year":"2006","unstructured":"Calabrese L . The yin and yang of tumor necrosis factor inhibitors. Cleve Clin J Med 2006; 73: 251\u2013256.","journal-title":"Cleve Clin J Med"},{"key":"BFgt200943_CR17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajo.2008.06.019","volume":"146","author":"JH Kempen","year":"2008","unstructured":"Kempen JH, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT et al. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol 2008; 146: 828\u2013836.","journal-title":"Am J Ophthalmol"},{"key":"BFgt200943_CR18","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V . Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275\u20132285.","journal-title":"JAMA"},{"key":"BFgt200943_CR19","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.21231","volume":"52","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et's disease: an open-label trial. Arthritis Rheum 2005; 52: 2478\u20132484.","journal-title":"Arthritis Rheum"},{"key":"BFgt200943_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1096\/fj.05-4737fje","volume":"20","author":"C Bloquel","year":"2006","unstructured":"Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D et al. Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J 2006; 20: 389\u2013391.","journal-title":"FASEB J"},{"key":"BFgt200943_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/jop.2006.0148","volume":"23","author":"M Diaz-Llopis","year":"2007","unstructured":"Diaz-Llopis M, Garc\u00eda-Delpech S, Salom D, Udaondo P, Bosch-Morell F, Quijada A et al. High-dose infliximab prophylaxis in endotoxin-induced uveitis. J Ocul Pharmacol Ther 2007; 23: 343\u2013350.","journal-title":"J Ocul Pharmacol Ther"},{"key":"BFgt200943_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/104303404772679995","volume":"15","author":"C Bloquel","year":"2004","unstructured":"Bloquel C, Bessis N, Boissier MC, Scherman D, Bigey P . Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Hum Gene Ther 2004; 15: 189\u2013201.","journal-title":"Hum Gene Ther"},{"key":"BFgt200943_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.exer.2004.06.001","volume":"79","author":"MC Avunduk","year":"2004","unstructured":"Avunduk MC, Avunduk AM, Oztekin E, Baltaci AK, Ozyazgan Y, Mogolkoc R . Etanercept treatment in the endotoxin-induced uveitis of rats. Exp Eye Res 2004; 79: 357\u2013365.","journal-title":"Exp Eye Res"},{"key":"BFgt200943_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/MAJ.0b013e3180318fbc","volume":"27","author":"PG Theodossiadis","year":"2007","unstructured":"Theodossiadis PG, Markomichelakis NN, Sfikakis PP . Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 2007; 27: 399\u2013413.","journal-title":"Retina"},{"key":"BFgt200943_CR25","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1167\/iovs.02-1156","volume":"44","author":"M Robertson","year":"2003","unstructured":"Robertson M, Liversidge J, Forrester JV, Dick AD . Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 2003; 44: 3034\u20133041.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200943_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","volume":"18","author":"FR Imrie","year":"2007","unstructured":"Imrie FR, Dick AD . Biologics in the treatment of uveitis. Curr Opin Ophthalmol 2007; 18: 481\u2013486.","journal-title":"Curr Opin Ophthalmol"},{"key":"BFgt200943_CR27","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1002\/art.22918","volume":"56","author":"LL Lim","year":"2007","unstructured":"Lim LL, Fraunfelder FW, Rosenbaum JT . Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum 2007; 56: 3248\u20133252.","journal-title":"Arthritis Rheum"},{"key":"BFgt200943_CR28","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V, Montero D, Pascual-G\u00f3mez E, Mola EM et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005; 52: 1766\u20131772.","journal-title":"Arthritis Rheum"},{"key":"BFgt200943_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","volume":"126","author":"J Lin","year":"2008","unstructured":"Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y et al. TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008; 126: 13\u201330.","journal-title":"Clin Immunol"},{"key":"BFgt200943_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1096\/fj.04-2073fje","volume":"19","author":"GH Waetzig","year":"2005","unstructured":"Waetzig GH, Rosenstiel P, Arlt A, Till A, Br\u00e4utigam K, Sch\u00e4fer H et al. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 2005; 19: 91\u201393.","journal-title":"FASEB J"},{"key":"BFgt200943_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2007.08.013","volume":"126","author":"M Wong","year":"2008","unstructured":"Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J et al. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008; 126: 121\u2013136.","journal-title":"Clin Immunol"},{"key":"BFgt200943_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.exer.2004.06.001","volume":"79","author":"MC Avunduk","year":"2004","unstructured":"Avunduk MC, Avunduk AM, Oztekin E, Baltaci AK, Ozyazgan Y, Mogolkoc R . Etanercept treatment in the endotoxin-induced uveitis of rats. Exp Eye Res 2004; 79: 357\u2013365.","journal-title":"Exp Eye Res"},{"key":"BFgt200943_CR33","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1167\/iovs.02-1156","volume":"44","author":"M Robertson","year":"2003","unstructured":"Robertson M, Liversidge J, Forrester JV, Dick AD . Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 2003; 44: 3034\u20133041.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200943_CR34","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1167\/iovs.08-3027","volume":"50","author":"L Kowalczuk","year":"2009","unstructured":"Kowalczuk L, Touchard E, Camelo S, Naud MC, Castaneda B, Brunel N et al. Local ocular immunomodulation results from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle. Invest Ophthalmol Vis 2009; 50: 1761\u20131768.","journal-title":"Invest Ophthalmol Vis"},{"key":"BFgt200943_CR35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/jgm.1088","volume":"9","author":"C Bloquel","year":"2007","unstructured":"Bloquel C, Denys A, Boissier MC, Apparailly F, Bigey P, Scherman D et al. Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic mice. J Gene Med 2007; 9: 986\u2013993.","journal-title":"J Gene Med"},{"key":"BFgt200943_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/exer.1997.0364","volume":"65","author":"FF Behar-Cohen","year":"1997","unstructured":"Behar-Cohen FF, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S et al. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res 1997; 65: 533\u2013545.","journal-title":"Exp Eye Res"},{"key":"BFgt200943_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02713680600701513","volume":"31","author":"A Labb\u00e9","year":"2006","unstructured":"Labb\u00e9 A, Liang H, Martin C, Brignole-Baudouin F, Warnet JM, Baudouin C . Comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope. Curr Eye Res 2006; 31: 501\u2013509.","journal-title":"Curr Eye Res"}],"updated-by":[{"DOI":"10.1038\/gt.2009.89","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,8,13]],"date-time":"2009-08-13T00:00:00Z","timestamp":1250121600000}}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt200943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200943","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:55:13Z","timestamp":1648547713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt200943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,14]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFgt200943"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.43","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/gt.2009.89","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,14]]},"assertion":[{"value":"3 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}